Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Interventional × Klatskin Tumor × Clear all

Phase

Status

Unknown 17 Completed 12 Recruiting 6 Terminated 5 Not yet recruiting 5 Active not recruiting 4 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 330 Neoplasms 216 Carcinoma, Non-Small-Cell Lung 194 Prostatic Neoplasms 168 Colorectal Neoplasms 126 Lung Neoplasms 115 Leukemia, Myeloid, Acute 114 Pancreatic Neoplasms 112 Neoplasm Metastasis 112 Multiple Myeloma 104 Lymphoma 100 Carcinoma, Hepatocellular 99 Melanoma 83 Ovarian Neoplasms 81 Head and Neck Neoplasms 81 Recurrence 78 Leukemia 77 Brain Neoplasms 75 Leukemia, Lymphocytic, Chronic, B-Cell 73 Glioblastoma 68 Precursor Cell Lymphoblastic Leukemia-Lymphoma 65 Squamous Cell Carcinoma of Head and Neck 64 Lymphoma, Non-Hodgkin 63 Colonic Neoplasms 61 Lymphoma, Follicular 59 Lymphoma, Large B-Cell, Diffuse 58 Hematologic Neoplasms 50 Carcinoma, Renal Cell 49 Rectal Neoplasms 48 Urinary Bladder Neoplasms 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03353181 2022-08-25

ENBD

Changhai Hospital

Phase NA Withdrawn

Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡